OmniComm Systems signs reseller agreement with Tri-I Biotech Shanghai
"We were looking for a partner who has a clinical trial system that manages clinical data and automates the data capture and laboratory processes in Phase I units,"
QIAGEN’s Digital Insights bioinformatics division is set to integrate NVIDIA’s accelerated computing and the BioNeMo platform to enhance AI-driven drug discovery.
Under the agreement, EyeGate will receive an upfront cash payment, development-based milestone payments related to the completion of development for the indication of anterior uveitis and an approval-based
The collaboration is based on combinations of Chimeric Antigen Receptor (CAR) T cells, developed at the laboratory of professor Hinrich Abken against multiple tumor-associated antigens, and apceth-developed engineered